Invesco S&P World Health Care ESG UCITS ETF (ETR:WH2E)

Assets	10.79M
Expense Ratio	0.20%
PE Ratio	24.29
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+22.82%

Volume	196
Open	6.05
Previous Close	6.03
Day's Range	6.03 - 6.12
52-Week Low	4.86
52-Week High	6.21
Beta	n/a
Holdings	81
Inception Date	Apr 12, 2023

About WH2E

WHCE.L was created on 2023-04-12 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The objective of the Fund is to aim to track the Net Total Return performance of the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index (the Index), less fees, expenses and transaction costs.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: WH2E
• Provider: Invesco
• Index Tracked: S&P World ESG Enhanced Health Care Index - Benchmark TR Net

Performance

WH2E had a total return of 22.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.17%.

Top 10 Holdings

63.92% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	16.02%
AbbVie Inc.	ABBV	11.78%
Merck & Co., Inc.	MRK	7.30%
AstraZeneca PLC	AZN	4.69%
Gilead Sciences, Inc.	GILD	4.56%
Roche Holding AG	ROP	4.33%
Novartis AG	NOVN	4.24%
Amgen Inc.	AMGN	3.69%
Abbott Laboratories	ABT	3.68%
Thermo Fisher Scientific Inc.	TMO	3.64%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error